Rhythm Pharmaceuticals (RYTM) Total Liabilities (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) posted quarterly Total Liabilities of $204.7 million for Q1 2026, down 8.45% year-over-year from $223.6 million in Q1 2025, and down 2.6% quarter-over-quarter from $210.2 million in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Total Liabilities (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has reported Total Liabilities for 11 consecutive years, with $204.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities fell 8.45% year-over-year to $204.7 million; the TTM figure through Mar 2026 stood at $204.7 million (down 8.45% YoY), while the FY2025 annual figure was $210.2 million, down 7.71% from the prior year.
- Total Liabilities eased to $204.7 million in Q1 2026 per RYTM's latest filing, from $210.2 million in the prior quarter.
- Across five years, Total Liabilities topped out at $239.2 million in Q2 2025 and bottomed at $49.1 million in Q1 2022.
- Historically, Total Liabilities has averaged $168.1 million across 5 years, with a median of $197.1 million in 2024.
- Annual changes were most pronounced in 2022 — Total Liabilities surged 223.06% — and 2026, when it slipped 8.45%.
- Rhythm Pharmaceuticals' Total Liabilities stood at $118.2 million in 2022, then jumped by 37.87% to $163.0 million in 2023, then jumped by 39.72% to $227.7 million in 2024, then retreated by 7.71% to $210.2 million in 2025, then declined by 2.6% to $204.7 million in 2026.
- Business Quant data shows RYTM's Total Liabilities at $204.7 million in Q1 2026, $210.2 million in Q4 2025, and $211.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.62 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 1.72 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 4.00 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 7.02 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 10.03 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.20 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Rhythm Pharmaceuticals | 7.95 Bn | 7.62 Bn | 62.32 Mn | 219.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 219.97 Mn |
| Mar 31, 2026 | 204.70 Mn |
| Dec 31, 2025 | 210.17 Mn |
| Sep 30, 2025 | 211.19 Mn |
| Jun 30, 2025 | 239.15 Mn |
| Mar 31, 2025 | 223.60 Mn |
| Dec 31, 2024 | 227.72 Mn |
| Sep 30, 2024 | 210.88 Mn |
| Jun 30, 2024 | 202.35 Mn |
| Mar 31, 2024 | 197.07 Mn |
| Dec 31, 2023 | 162.99 Mn |
| Sep 30, 2023 | 156.73 Mn |
| Jun 30, 2023 | 127.66 Mn |
| Mar 31, 2023 | 125.92 Mn |
| Dec 31, 2022 | 118.22 Mn |
| Sep 30, 2022 | 108.42 Mn |
| Jun 30, 2022 | 82.05 Mn |
| Mar 31, 2022 | 49.06 Mn |
| Dec 31, 2021 | 45.37 Mn |
| Sep 30, 2021 | 33.56 Mn |